CSM Advisors Portfolio holdings
CS McKee manages money for institutions such as pension funds, endowments, unions, hospitals and schools, in a business that dates to 1931. The company that runs it, CSM Advisors, was set up in 2020 to continue that business. It offers fixed income, multi-asset and equity strategies, and its large cap value stock strategy combines in-house computer models with traditional company research. CS McKee also manages money for some funds sponsored by North Square Investments, and since January 2026 Azimut NSI, a subsidiary of the Azimut Group, has held ownership interests in both firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSIV
North Square Disciplined Value ETF
NSIV
|
+$72.4M |
| 2 |
NSIG
North Square Growth Opportunities ETF
NSIG
|
+$60.8M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$44.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$35.6M |
| 5 |
SS&C Technologies
SSNC
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.6M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$52M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
iShare MSCI Eurozone ETF
EZU
|
+$50.1M |
| 5 |
Cisco
CSCO
|
+$36.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Miscellaneous | 17.03% |
| 3 | Financials | 15.5% |
| 4 | Industrials | 8.74% |
| 5 | Healthcare | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Pelagos Insurance Capital
PLGO
$2.28B
| $9.8M | 0.21% |
413,576
-97,130
| -19% | -$2.4M |
2025 Q2
5 quarters
|
|
102
OneSpan
OSPN
$823M
| $9.7M | 0.21% |
544,002
+118,082
| +28% | +$1.91M |
2025 Q2
5 quarters
|
|
103
Covenant Logistics
CVLG
$828M
| $9.7M | 0.21% |
300,239
-9,982
| -3% | -$381K |
2025 Q2
5 quarters
|
|
104
OFG Bancorp
OFG
$2.16B
| $9.6M | 0.21% |
192,604
-114,405
| -37% | -$5.94M |
2025 Q2
5 quarters
|
|
105
Walmart Inc
WMT
$1.02T
| $9.5M | 0.21% |
91,449
-2,857
| -3% | -$314K |
2021 Q1
22 quarters
|
|
106
ANI Pharmaceuticals
ANIP
$1.62B
| $9.5M | 0.2% |
130,804
+29,944
| +30% | +$2.31M |
2026 Q1
2 quarters
|
|
107
VersaBank
VBNK
$772M
| $9.49M | 0.2% |
427,021
+66,285
| +18% | +$1.39M |
2025 Q3
4 quarters
|
|
108
CrowdStrike
CRWD
$232B
| $9.36M | 0.2% |
35,362
-342
| -1% | -$72.6K |
2025 Q3
4 quarters
|
|
109
Standard Motor Products
SMP
$984M
| $9.34M | 0.2% |
251,947
+36,749
| +17% | +$1.41M |
2025 Q2
5 quarters
|
|
110
Dime Commercial Bancshares
DCOM
$1.85B
| $9.34M | 0.2% |
237,071
-1,880
| -0.8% | -$76K |
2025 Q2
5 quarters
|
|
111
Easterly Government Properties
DEA
$1.04B
| $9.29M | 0.2% |
400,500
+262,920
| +191% | +$6.43M |
2026 Q2
1 quarter
|
|
112
Genco Shipping & Trading
GNK
$1.14B
| $9.26M | 0.2% |
354,033
-8,892
| -2% | -$231K |
2025 Q2
5 quarters
|
|
113
Kroger
KR
$41.8B
| $9.22M | 0.2% |
157,270
-4,860
| -3% | -$283K |
2025 Q2
5 quarters
|
|
114
Pediatrix Medical
MD
$2.45B
| $9.16M | 0.2% |
356,187
-77,458
| -18% | -$2.04M |
2025 Q2
5 quarters
|
|
115
Mercado Libre
MELI
$75.6B
| $9.09M | 0.2% |
5,260
+1,284
| +32% | +$2.38M |
2026 Q1
2 quarters
|
|
116
Peoples Bancorp
PEBO
$1.38B
| $8.83M | 0.19% |
241,301
+1,839
| +0.8% | +$73.2K |
2025 Q2
5 quarters
|
|
117
American Assets Trust
AAT
$1.33B
| $8.76M | 0.19% |
412,014
+74,018
| +22% | +$1.71M |
2026 Q1
2 quarters
|
|
118
Allegiant Air
ALGT
$2.52B
| $8.65M | 0.19% |
114,176
+52,320
| +85% | +$4.71M |
2025 Q4
3 quarters
|
|
119
SM Energy
SM
$7.69B
| $8.61M | 0.19% |
254,772
+4,005
| +2% | +$134K |
2025 Q2
5 quarters
|
|
120
Metallus
MTUS
$699M
| $8.4M | 0.18% |
441,979
+55,972
| +15% | +$1.11M |
2025 Q3
4 quarters
|
|
121
SmartFinancial
SMBK
$822M
| $8.39M | 0.18% |
169,285
-14,750
| -8% | -$744K |
2025 Q2
5 quarters
|
|
122
National Fuel Gas
NFG
$7.29B
| $8.23M | 0.18% |
108,513
+3,722
| +4% | +$302K |
2026 Q1
2 quarters
|
|
123
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.9B
| $8.18M | 0.18% |
162,925
| – | – |
2023 Q4
11 quarters
|
|
124
Terex
TEX
$6.4B
| $8.16M | 0.18% |
155,067
-3,623
| -2% | -$231K |
2025 Q2
5 quarters
|
|
125
Koppers
KOP
$586M
| $8.14M | 0.18% |
178,660
-15,685
| -8% | -$745K |
2025 Q2
5 quarters
|
|
Similar funds
CSM Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, CSM Advisors held 435 positions worth $4.64B, down 0.97% from $4.68B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
CSM Advisors's Q3 2026 filing shows 29 new, 160 increased, 189 reduced and 36 closed positions. Its largest new stake was North Square Disciplined Value ETF: 2,802,055 shares worth $70.8M. The largest sale was Johnson & Johnson, an estimated $55.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Financials.
- CSM Advisors's largest Q3 2026 buy was North Square Disciplined Value ETF: 2,802,055 shares worth $70.8M.
- CSM Advisors added most to Bristol-Myers Squibb in Q3 2026, an estimated $35.6M increase.
- CSM Advisors's biggest Q3 2026 reduction was Johnson & Johnson, cutting an estimated $55.6M.
- CSM Advisors fully exited iShare MSCI Eurozone ETF in Q3 2026, selling an estimated $50.1M.
- CSM Advisors's ten largest holdings make up 25% of its $4.64B portfolio in Q3 2026.
- CSM Advisors opened 29 new positions and closed 36 in Q3 2026.
- CSM Advisors's portfolio value fell 0.97% quarter-over-quarter to $4.64B.
Based on CSM Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.